Suppr超能文献

肺综合分配评分系统对美国肺移植的预期效果。

Expected effect of the lung Composite Allocation Score system on US lung transplantation.

机构信息

Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA.

出版信息

Am J Transplant. 2022 Dec;22(12):2971-2980. doi: 10.1111/ajt.17160. Epub 2022 Aug 9.

Abstract

Efforts are underway to transition the current lung allocation system to a continuous distribution framework whereby multiple factors are simultaneously combined into a Composite Allocation Score (CAS) to prioritize candidates for lung transplant. The purpose of this study was to compare discrete CAS scenarios with the current concentric circle-based allocation system to assess their potential effects on the US lung transplantation system using the Scientific Registry of Transplant Recipients' thoracic simulated allocation model. Six alternative CAS scenarios were compared over 10 simulation runs using data from individuals on the lung transplant waiting list from January 1, 2018, through December 31, 2019. Outcome measures were transplant rate, count, waitlist deaths, posttransplant deaths within 2 years, donor-to-recipient distance, and percentage of organs predicted to have flown. Across scenarios, waitlist deaths decreased by 36% to 47%, with larger decreases in deaths at lower placement efficiency weight and higher weighting of the waitlist outcomes. When waitlist outcomes were equally weighted to posttransplant outcomes, more transplants occurred in individuals with the highest expected posttransplant survival. All CAS scenarios led to improved overall measures of equity compared with the current Lung Allocation Score system, including reduced waitlist deaths, and resulted in similar posttransplant survival.

摘要

目前正在努力将现行的肺分配系统转变为连续分配框架,即将多个因素同时综合到综合分配评分(CAS)中,以优先考虑肺移植的候选人。本研究的目的是通过使用 Scientific Registry of Transplant Recipients 的胸部模拟分配模型,将离散的 CAS 方案与现行的基于同心环的分配系统进行比较,以评估它们对美国肺移植系统的潜在影响。使用 2018 年 1 月 1 日至 2019 年 12 月 31 日期间在肺移植等候名单上的个人数据,在 10 次模拟运行中比较了 6 种替代的 CAS 方案。结果指标包括移植率、移植数量、等候名单死亡人数、移植后 2 年内死亡人数、供体与受体之间的距离以及预计飞行器官的百分比。在所有方案中,等候名单上的死亡人数减少了 36%至 47%,在放置效率权重较低和等候名单结果权重较高的情况下,死亡人数减少幅度更大。当等候名单结果与移植后结果同等加权时,预计移植后存活最高的个体接受的移植数量更多。与现行的肺分配评分系统相比,所有 CAS 方案都改善了公平性的整体衡量标准,包括减少等候名单死亡人数,并导致相似的移植后存活。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验